Literature DB >> 29806830

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord.

Karen Haenraets1, Gioele W Albisetti2, Edmund Foster2, Hendrik Wildner3.   

Abstract

Selective manipulation of spinal neuronal subpopulations has mainly been achieved by two different methods: 1) Intersectional genetics, whereby double or triple transgenic mice are generated in order to achieve selective expression of a reporter or effector gene (e.g., from the Rosa26 locus) in the desired spinal population. 2) Intraspinal injection of Cre-dependent recombinant adeno-associated virus (rAAV); here Cre-dependent AAV vectors coding for the reporter or effector gene of choice are injected into the spinal cord of mice expressing Cre recombinase in the desired neuronal subpopulation. This protocol describes how to generate Cre-dependent rAAV vectors and how to transduce neurons in the dorsal horn of the lumbar spinal cord segments L3-L5 with rAAVs. As the lumbar spinal segments L3-L5 are innervated by those peripheral sensory neurons that transmit sensory information from the hindlimbs, spontaneous behavior and responses to sensory tests applied to the hindlimb ipsilateral to the injection side can be analyzed in order to interrogate the function of the manipulated neurons in sensory processing. We provide examples of how this technique can be used to analyze genetically defined subsets of spinal neurons. The main advantages of virus-mediated transgene expression in Cre transgenic mice compared to classical reporter mouse-induced transgene expression are the following: 1) Different Cre-dependent rAAVs encoding various reporter or effector proteins can be injected into a single Cre transgenic line, thus overcoming the need to create several multiple transgenic mouse lines. 2) Intraspinal injection limits manipulation of Cre-expressing cells to the injection site and to the time after injection. The main disadvantages are: 1) Reporter gene expression from rAAVs is more variable. 2) Surgery is required to transduce the spinal neurons of interest. Which of the two methods is more appropriate depends on the neuron population and research question to be addressed.

Entities:  

Mesh:

Year:  2018        PMID: 29806830      PMCID: PMC6101182          DOI: 10.3791/57382

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  23 in total

1.  Identification of a spinal circuit for light touch and fine motor control.

Authors:  Steeve Bourane; Katja S Grossmann; Olivier Britz; Antoine Dalet; Marta Garcia Del Barrio; Floor J Stam; Lidia Garcia-Campmany; Stephanie Koch; Martyn Goulding
Journal:  Cell       Date:  2015-01-29       Impact factor: 41.582

2.  Gate control of mechanical itch by a subpopulation of spinal cord interneurons.

Authors:  Steeve Bourane; Bo Duan; Stephanie C Koch; Antoine Dalet; Olivier Britz; Lidia Garcia-Campmany; Euiseok Kim; Longzhen Cheng; Anirvan Ghosh; Qiufu Ma; Martyn Goulding
Journal:  Science       Date:  2015-10-30       Impact factor: 47.728

3.  Identification of Early RET+ Deep Dorsal Spinal Cord Interneurons in Gating Pain.

Authors:  Lian Cui; Xuerong Miao; Lingli Liang; Ishmail Abdus-Saboor; William Olson; Michael S Fleming; Minghong Ma; Yuan-Xiang Tao; Wenqin Luo
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

4.  Identifying local and descending inputs for primary sensory neurons.

Authors:  Yi Zhang; Shengli Zhao; Erica Rodriguez; Jun Takatoh; Bao-Xia Han; Xiang Zhou; Fan Wang
Journal:  J Clin Invest       Date:  2015-08-31       Impact factor: 14.808

5.  A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins.

Authors:  Amaury François; Sarah A Low; Elizabeth I Sypek; Amelia J Christensen; Chaudy Sotoudeh; Kevin T Beier; Charu Ramakrishnan; Kimberly D Ritola; Reza Sharif-Naeini; Karl Deisseroth; Scott L Delp; Robert C Malenka; Liqun Luo; Adam W Hantman; Grégory Scherrer
Journal:  Neuron       Date:  2017-02-02       Impact factor: 17.173

Review 6.  Fast synaptic inhibition in spinal sensory processing and pain control.

Authors:  Hanns Ulrich Zeilhofer; Hendrik Wildner; Gonzalo E Yévenes
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

7.  Targeted ablation, silencing, and activation establish glycinergic dorsal horn neurons as key components of a spinal gate for pain and itch.

Authors:  Edmund Foster; Hendrik Wildner; Laetitia Tudeau; Sabine Haueter; William T Ralvenius; Monika Jegen; Helge Johannssen; Ladina Hösli; Karen Haenraets; Alexander Ghanem; Karl-Klaus Conzelmann; Michael Bösl; Hanns Ulrich Zeilhofer
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

8.  The Cellular and Synaptic Architecture of the Mechanosensory Dorsal Horn.

Authors:  Victoria E Abraira; Emily D Kuehn; Anda M Chirila; Mark W Springel; Alexis A Toliver; Amanda L Zimmerman; Lauren L Orefice; Kieran A Boyle; Ling Bai; Bryan J Song; Karleena A Bashista; Thomas G O'Neill; Justin Zhuo; Connie Tsan; Jessica Hoynoski; Michael Rutlin; Laura Kus; Vera Niederkofler; Masahiko Watanabe; Susan M Dymecki; Sacha B Nelson; Nathaniel Heintz; David I Hughes; David D Ginty
Journal:  Cell       Date:  2016-12-29       Impact factor: 41.582

9.  A new minimally-invasive method for microinjection into the mouse spinal dorsal horn.

Authors:  Yuta Kohro; Emi Sakaguchi; Ryoichi Tashima; Hidetoshi Tozaki-Saitoh; Hideyuki Okano; Kazuhide Inoue; Makoto Tsuda
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

10.  Preprotachykinin A is expressed by a distinct population of excitatory neurons in the mouse superficial spinal dorsal horn including cells that respond to noxious and pruritic stimuli.

Authors:  Maria Gutierrez-Mecinas; Andrew M Bell; Alina Marin; Rebecca Taylor; Kieran A Boyle; Takahiro Furuta; Masahiko Watanabe; Erika Polgár; Andrew J Todd
Journal:  Pain       Date:  2017-03       Impact factor: 7.926

View more
  8 in total

1.  Dorsal Horn Gastrin-Releasing Peptide Expressing Neurons Transmit Spinal Itch But Not Pain Signals.

Authors:  Gioele W Albisetti; Martina Pagani; Evgenia Platonova; Ladina Hösli; Helge C Johannssen; Jean-Marc Fritschy; Hendrik Wildner; Hanns Ulrich Zeilhofer
Journal:  J Neurosci       Date:  2019-01-17       Impact factor: 6.167

Review 2.  Surgical preparations, labeling strategies, and optical techniques for cell-resolved, in vivo imaging in the mouse spinal cord.

Authors:  Yu-Ting Cheng; Kawasi M Lett; Chris B Schaffer
Journal:  Exp Neurol       Date:  2019-05-13       Impact factor: 5.330

3.  Electroacupuncture Alleviates Neuropathic Pain through Regulating miR-206-3p Targeting BDNF after CCI.

Authors:  Wenzhan Tu; Jingjing Yue; Xuqing Li; Qiaoyun Wu; Guanhu Yang; Shengcun Li; Qiangsan Sun; Songhe Jiang
Journal:  Neural Plast       Date:  2022-06-09       Impact factor: 3.144

4.  Viral strategies for targeting spinal neuronal subtypes in adult wild-type rodents.

Authors:  Jaspreet Kaur; Rune W Berg
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

5.  The Neurokinin-1 Receptor is Expressed with Gastrin-Releasing Peptide Receptor in Spinal Interneurons and Modulates Itch.

Authors:  Tayler D Sheahan; Charles A Warwick; Louis G Fanien; Sarah E Ross
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

6.  Neuroligin1 Contributes to Neuropathic Pain by Promoting Phosphorylation of Cofilin in Excitatory Neurons.

Authors:  Junlin Ouyang; Xiaping Chen; Shanchun Su; Xiaohui Li; Xueqin Xu; Xinhua Yu; Changbin Ke; Xiaohu Zhu
Journal:  Front Mol Neurosci       Date:  2021-02-25       Impact factor: 5.639

Review 7.  Targeting spinal neuropeptide Y1 receptor-expressing interneurons to alleviate chronic pain and itch.

Authors:  Tyler S Nelson; Bradley K Taylor
Journal:  Prog Neurobiol       Date:  2020-08-07       Impact factor: 11.685

8.  Spinally projecting noradrenergic neurons of the locus coeruleus display resistance to AAV2retro-mediated transduction.

Authors:  Robert P Ganley; Kira Werder; Hendrik Wildner; Hanns Ulrich Zeilhofer
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.